“My Take: A Milestone That Actually Feels Earned”
I’ve always viewed Injective as one of the most focused, underrated chains in the market — not because it lacked tech, but because it refused to chase noise.
This new ETP confirms what many early supporters believed: Injective was building for institutions long before institutions were ready.
A regulated product holding real INJ
Staking rewards integrated
Backed by serious capital
Listed on major European markets
It’s a turning point — not a temporary pump.
Injective now sits at a crossroads where decentralized finance meets traditional financial infrastructure.
And honestly?
It’s about time this ecosystem gets the spotlight it has earned.
